ASCO

5 takeaways from the first look at cancer's biggest conference
Biopharma Dive
Thu, 05/17/18 - 10:44 pm
ASCO
Regeneron
cemiplimab
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
Nektar
NKTR-214
Loxo Oncology
LOXO-292
Jounce Therapeutics
JTX-2011
Deal struck to mine cancer patient database for new treatment insights
Stat
Thu, 12/21/17 - 10:41 pm
patients
cancer
ASCO
CancerLinQ
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
Tue, 09/5/17 - 09:35 am
ASCO
IPOs
biotech
Deciphera
DCC-2618
Nucana
Acelarin
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb
AstraZeneca looks to DNA damage-response drugs for edge in oncology
BioPharma Dive
Tue, 05/17/16 - 09:25 am
AstraZeneca
oncology
ASCO
Lynparza
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Roche
ASCO
immuno-oncology
Amgen
Merck
Bristol-Myers Squibb
Lilly's Alimta gets rating boost in update to ASCO's drug scorecard
Fierce Pharma
Wed, 07/15/15 - 12:23 pm
Eli Lilly
Alimta
ASCO
lung cancer
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
biotech
ASCO
Immunogen
Exelixis
Oncothyreon
CTI BioPharma
Immunomedics
Vascular Biogenics
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
ASCO
Ignyta
Immunogen
Puma Biotechnology
AbbVie
Roche
Bristol-Myers Squibb
Seattle Genetics
Juno Therapeutics
Amgen: The Quiet Winner
Barron's
Wed, 06/3/15 - 12:36 pm
Amgen
ASCO
Kyprolis
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
Wed, 06/3/15 - 11:04 am
ASCO
cancer immunotherapy
glioblastoma multiforme
Merck
Genentech
Celldex Therapeutics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
The 4 Overlooked Winners of ASCO
24/7 Wall St
Tue, 06/2/15 - 09:12 am
ASCO
Bristol-Myers Squibb
AbbVie
Aveo Pharmaceuticals
Ignyta
Merck KGaA sees immunotherapy drug holding its own in cancer race
Yahoo/Reuters
Tue, 06/2/15 - 09:06 am
Merck KGaA
avelumab
Pfizer
ASCO
cancer immunotherapy
Pfizer's Ibrance Takes Another Giant Leap Forward
Investopedia
Tue, 06/2/15 - 09:03 am
Pfizer
Ibrance
ASCO
breast cancer
The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years
Forbes
Mon, 06/1/15 - 11:34 pm
ASCO
PDL-1 inhibitors
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
Pfizer gaining market share in oncology: CEO
CNBC
Mon, 06/1/15 - 07:46 pm
Pfizer
oncology
Pharma CEOs
Ian Read
ASCO
At ASCO: Bristol-Myers Rises on More Data About Cancer Drug
Barron's
Mon, 06/1/15 - 07:11 pm
ASCO
Bristol-Myers Squibb
Opdivo
ASCO 15: The top 10 setbacks, advances and head scratchers
Fierce Biotech
Mon, 06/1/15 - 12:15 pm
ASCO
Celldex Therapeutics
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Clovis Oncology
AstraZeneca
Genentech

Pages